PPIST16218
Protein Information
| Protein_Chain | A;B |
|---|---|
| Protein_Sequence | SGFRKMAFPSGKVEGCMVQVTCGTTTLNGLWLDDVVYCPRHVICTSEDMLNPNYEDLLIRKSNHNFLVQAGNVQLRVIGHSMQNCVLKLKVDTANPKTPKYKFVRIQPGQTFSVLACYNGSPSGVYQCAMRPNFTIKGSFLNGSCGSVGFNIDYDCVSFCYMHHMELPTGVHAGTDLEGNFYGPFVDRQTAQAAGTDTTITVNVLAWLYAAVINGDRWFLNRFTTTLNDFNLVAMKYNYEPLTQDHVDILGPLSAQTGIAVLDMCASLKELLQNGMNGRTILGSALLEDEFTPFDVVRQCSGVTFQ |
Peptide Information
| Peptide_Chain | C;D |
|---|---|
| Peptide_Sequence | XYFHXLNLGYRPGCX |
| Peptide_Length | 15 |
| Non-standard residues | Yes |
Interaction Information
| PDB_ID | 7Z4S |
|---|---|
| Method | X-RAY DIFFRACTION |
| Resolution | 1.70 angstrom |
| Structure | |
| Protein-peptide residue interaction | |
| Interaction_xlsx | Download interaction table (.xlsx) |
Reference Information
| Title | In vitro selection of macrocyclic peptide inhibitors containing cyclic gamma 2,4 -amino acids targeting the SARS-CoV-2 main protease. |
|---|---|
| Release_Year | 2023 |
| PMID | 37217786 |
| DOI | 10.1038/s41557-023-01205-1 |